Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1966
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 4
1968 2
1970 3
1971 1
1972 3
1973 3
1974 3
1975 11
1976 6
1977 14
1978 5
1979 8
1980 10
1981 16
1982 10
1983 16
1984 25
1985 19
1986 25
1987 16
1988 23
1989 26
1990 35
1991 27
1992 41
1993 60
1994 69
1995 57
1996 64
1997 74
1998 58
1999 85
2000 95
2001 86
2002 91
2003 123
2004 129
2005 118
2006 164
2007 177
2008 163
2009 147
2010 192
2011 218
2012 215
2013 225
2014 252
2015 237
2016 276
2017 328
2018 303
2019 268
2020 312
2021 338
2022 295
2023 244
2024 316
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

5,518 results

Results by year

Filters applied: . Clear all
Page 1
Huntington's disease: diagnosis and management.
Stoker TB, Mason SL, Greenland JC, Holden ST, Santini H, Barker RA. Stoker TB, et al. Pract Neurol. 2022 Feb;22(1):32-41. doi: 10.1136/practneurol-2021-003074. Epub 2021 Aug 19. Pract Neurol. 2022. PMID: 34413240 Review.
Huntington's disease (HD) is an inherited neurodegenerative disease characterised by neuropsychiatric symptoms, a movement disorder (most commonly choreiform) and progressive cognitive impairment. ...Though diagnosis is usually straightforward, unusual presen …
Huntington's disease (HD) is an inherited neurodegenerative disease characterised by neuropsychiatric symptoms, a movem …
Huntington's disease: a clinical review.
McColgan P, Tabrizi SJ. McColgan P, et al. Eur J Neurol. 2018 Jan;25(1):24-34. doi: 10.1111/ene.13413. Epub 2017 Sep 22. Eur J Neurol. 2018. PMID: 28817209 Review.
Huntington's disease (HD) is a fully penetrant neurodegenerative disease caused by a dominantly inherited CAG trinucleotide repeat expansion in the huntingtin gene on chromosome 4. ...Early macroscopic changes are seen in the striatum with involvement of the …
Huntington's disease (HD) is a fully penetrant neurodegenerative disease caused by a dominantly inherited CAG trinucleo …
Huntington's disease.
Walker FO. Walker FO. Lancet. 2007 Jan 20;369(9557):218-28. doi: 10.1016/S0140-6736(07)60111-1. Lancet. 2007. PMID: 17240289 Review.
Huntington's disease is an autosomal-dominant, progressive neurodegenerative disorder with a distinct phenotype, including chorea and dystonia, incoordination, cognitive decline, and behavioural difficulties. ...The precise pathophysiological mechanisms of Huntin …
Huntington's disease is an autosomal-dominant, progressive neurodegenerative disorder with a distinct phenotype, including cho …
Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.
Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC. Jimenez-Sanchez M, et al. Cold Spring Harb Perspect Med. 2017 Jul 5;7(7):a024240. doi: 10.1101/cshperspect.a024240. Cold Spring Harb Perspect Med. 2017. PMID: 27940602 Free PMC article. Review.
Huntington's disease is a late-onset neurodegenerative disease caused by a CAG trinucleotide repeat in the gene encoding the huntingtin protein. ...Finally, we outline some of the therapeutic strategies that are currently being pursued to slow down the dis …
Huntington's disease is a late-onset neurodegenerative disease caused by a CAG trinucleotide repeat in the gene encodin …
New Avenues for the Treatment of Huntington's Disease.
Kim A, Lalonde K, Truesdell A, Gomes Welter P, Brocardo PS, Rosenstock TR, Gil-Mohapel J. Kim A, et al. Int J Mol Sci. 2021 Aug 4;22(16):8363. doi: 10.3390/ijms22168363. Int J Mol Sci. 2021. PMID: 34445070 Free PMC article. Review.
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion in the HD gene. The disease is characterized by neurodegeneration, particularly in the striatum and cortex. ...
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion in the HD gene. The disease is char …
Clinical Features of Huntington's Disease.
Ghosh R, Tabrizi SJ. Ghosh R, et al. Adv Exp Med Biol. 2018;1049:1-28. doi: 10.1007/978-3-319-71779-1_1. Adv Exp Med Biol. 2018. PMID: 29427096 Review.
Huntington's disease (HD) is the most common monogenic neurodegenerative disease and the commonest genetic dementia in the developed world. ...Since the discovery of the gene over 20 years ago much progress has been made in HD research, and although there are …
Huntington's disease (HD) is the most common monogenic neurodegenerative disease and the commonest genetic dementia in …
Huntington disease.
Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ. Bates GP, et al. Nat Rev Dis Primers. 2015 Apr 23;1:15005. doi: 10.1038/nrdp.2015.5. Nat Rev Dis Primers. 2015. PMID: 27188817 Review.
Huntington disease is devastating to patients and their families - with autosomal dominant inheritance, onset typically in the prime of adult life, progressive course, and a combination of motor, cognitive and behavioural features. ...In this Primer, we review the e …
Huntington disease is devastating to patients and their families - with autosomal dominant inheritance, onset typically in the …
CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease.
Alkanli SS, Alkanli N, Ay A, Albeniz I. Alkanli SS, et al. Mol Neurobiol. 2023 Mar;60(3):1486-1498. doi: 10.1007/s12035-022-03150-5. Epub 2022 Dec 9. Mol Neurobiol. 2023. PMID: 36482283 Free PMC article. Review.
The pathogenic mechanisms of these diseases must be well understood for the treatment of neurological disorders such as Huntington's disease. Huntington's Disease (HD), a dominant and neurodegenerative disease, is characterized by the CAG re-exp …
The pathogenic mechanisms of these diseases must be well understood for the treatment of neurological disorders such as Huntington's …
Physical Therapy and Exercise Interventions in Huntington's Disease: A Mixed Methods Systematic Review.
Fritz NE, Rao AK, Kegelmeyer D, Kloos A, Busse M, Hartel L, Carrier J, Quinn L. Fritz NE, et al. J Huntingtons Dis. 2017;6(3):217-235. doi: 10.3233/JHD-170260. J Huntingtons Dis. 2017. PMID: 28968244 Free PMC article. Review.
BACKGROUND: A number of studies evaluating physical therapy and exercise interventions in Huntington's disease have been conducted over the past 15 years. However, an assessment of the quality and strength of the evidence in support of these interventions is lacking …
BACKGROUND: A number of studies evaluating physical therapy and exercise interventions in Huntington's disease have been condu …
A biological classification of Huntington's disease: the Integrated Staging System.
Tabrizi SJ, Schobel S, Gantman EC, Mansbach A, Borowsky B, Konstantinova P, Mestre TA, Panagoulias J, Ross CA, Zauderer M, Mullin AP, Romero K, Sivakumaran S, Turner EC, Long JD, Sampaio C; Huntington's Disease Regulatory Science Consortium (HD-RSC). Tabrizi SJ, et al. Lancet Neurol. 2022 Jul;21(7):632-644. doi: 10.1016/S1474-4422(22)00120-X. Lancet Neurol. 2022. PMID: 35716693 Review.
The HD-ISS characterises individuals for research purposes from birth, starting at Stage 0 (ie, individuals with the Huntington's disease genetic mutation without any detectable pathological change) by using a genetic definition of Huntington's disease …
The HD-ISS characterises individuals for research purposes from birth, starting at Stage 0 (ie, individuals with the Huntington's …
Cite
5,518 results